Molina Healthcare Inc. Reports Challenging Q2 2026 Financial Results
Molina Healthcare, Inc., a prominent managed healthcare organization, released its financial results for the second quarter of 2026, revealing significant challenges in membership and revenue. The company, which operates under Medicaid, Medicare, and state insurance marketplaces, reported a notable decrease in net income and premium revenue compared to the same period last year.
1. Overview of the Results
Key Financial Metrics
For the second quarter ending June 30, 2026, Molina Healthcare reported:
- Net Income: $60 million, or $1.19 per diluted share
- Premium Revenue: $10.2 billion, a decrease of 6% from Q2 2025
- Membership: 4.9 million members, down 14% from the previous year
- Consolidated Medical Care Ratio (MCR): Increased to 92.2%, up from 90.4% in Q2 2025
- General and Administrative (G&A) Expense Ratio: Increased to 6.7%, compared to 6.2% in the prior year
| Jul 2025 | Jul 2026 | |
|---|---|---|
Net Income | 1.13B | -7M |
Profit | 1.13B | -7M |
Net Income Continuing | 1.13B | -7M |
Income Tax Expense | 369M | 1M |
Pretax Income | 1.49B | -6M |
Non-operating Income | -154M | -209M |
Operating Income | 1.65B | 203M |
Revenue | 43.41B | 44.52B |
Costs and Expenses | 41.76B | 44.31B |
Cost of Revenue | 36.95B | 38.89B |
Operating Expenses | 4.80B | 5.42B |
Depreciation, Depletion & Amortization | 201M | 168M |
Impairment Expense | 0 | 93M |
Selling, General & Administrative | 2.82B | 3.02B |
Other Operating Expenses | 1.77B | 2.14B |
Consolidated Results
The financial results for the first half of 2026 painted a stark contrast to the same period in 2025. Net income plummeted to $74 million, or $1.46 per diluted share, compared to $553 million, or $10.19 per diluted share, in 2025. Contributing factors included a significant impairment charge of $93 million related to the planned exit from the Medicare Advantage Prescription Drug (MAPD) product in 2027.
2. Premium Revenue Decline and Medical Care Ratio
Premium Revenue Analysis
The decrease in premium revenue by $624 million in Q2 2026 was largely driven by a drop in membership across all segments. The MCR's rise to 92.2% reflects the increasing medical costs that the company is facing, a trend that has affected profitability across the board.
3. Trends and Uncertainties
Legislative and Regulatory Developments
The healthcare landscape is undergoing significant changes due to legislative actions. The One Big Beautiful Bill Act (OBBBA), enacted in July 2025, is anticipated to reduce Medicaid enrollment and, consequently, premium revenues. This act introduces work requirements and cost-sharing for Medicaid expansion, which Molina Healthcare will need to navigate carefully.
Marketplace Program Integrity and Affordability Rule
In June 2025, the Department of Health and Human Services implemented a rule that shortens the open enrollment period and tightens eligibility verification. Legal challenges to this rule could further complicate Molina's revenue outlook and enrollment figures.
4. Recent Developments and Contracts
Despite the current challenges, Molina Healthcare secured several new contracts that may bolster future operations:
- Wisconsin: Family Care and Family Care Partnership programs, effective January 1, 2027.
- Illinois: HealthChoice Illinois Medicaid Managed Care program, effective January 1, 2027.
- Florida: Florida Kids program, expected to serve approximately 120,000 enrollees starting October 1, 2026.
5. Business Trends and Future Outlook
Molina Healthcare anticipates a continued decline in Medicaid enrollment, projecting a reduction to about 4.5 million members by the end of 2026. The company is also bracing for a 12% decrease in Medicare enrollment, particularly within the MAPD segment, and expects Marketplace enrollment to drop to around 250,000 members.
Reportable Segments Performance
Molina operates four reportable segments: Medicaid, Medicare, Marketplace, and Other. The Medicaid segment saw a slight increase in premium revenue for Q2, but the overall trend remains concerning due to the broader market contraction.
6. Financial Condition and Capital Resources
As of June 30, 2026, Molina Healthcare's working capital stood at $5.2 billion, with total cash and investments reported at $9.2 billion. The company is committed to maintaining liquidity to meet regulatory compliance and operational needs.
| Jul 2025 | Jul 2026 | |
|---|---|---|
Total Assets | 16.20B | 16.00B |
Total Current Assets | 13.11B | 12.92B |
Cash and Equivalents | 4.49B | 4.98B |
Short-term Investments | 4.31B | 3.93B |
Prepaid Expenses | 438M | 528M |
Total Non-current Assets | 3.09B | 3.07B |
Intangible Assets | 2.16B | 2.08B |
Non-current Deferred Tax Assets | 185M | 229M |
Net PP&E | 305M | 311M |
Other Non-current Assets | 439M | 453M |
Total Liabilities and Equity | 16.20B | 16.00B |
Total Liabilities | 11.60B | 11.83B |
Total Current Liabilities | 7.87B | 7.7B |
Accounts Payable and Accrued Liabilities | 1.11B | 1.13B |
Current Deferred Revenue | 57M | 69M |
Other Current Liabilities | 6.70B | 6.49B |
Total Non-current Liabilities | 3.73B | 4.13B |
Long-term Debt | 3.56B | 3.95B |
Other Non-current Liabilities | 167M | 179M |
Total Equity and Non-controlling Interests | 4.60B | 4.17B |
Total Equity | 4.60B | 4.17B |
7. Debt Ratings and Financial Covenants
In April 2026, Standard & Poor’s downgraded the rating of Molina Healthcare's senior notes, reflecting ongoing challenges in the market. However, the company remains compliant with all financial covenants under its credit agreements and other long-term debt obligations.
8. Conclusion
Molina Healthcare's Q2 2026 report highlights a turbulent period characterized by declining membership and revenue, alongside increasing medical costs. As the company adapts to evolving regulatory landscapes and navigates market challenges, its future growth strategy will likely emphasize organic growth and targeted acquisitions. Investors and stakeholders will be closely monitoring how these dynamics unfold in the coming quarters.
